420 related articles for article (PubMed ID: 20086171)
21. Carbon source metabolism and its regulation in cancer cells.
Yin C; Qie S; Sang N
Crit Rev Eukaryot Gene Expr; 2012; 22(1):17-35. PubMed ID: 22339657
[TBL] [Abstract][Full Text] [Related]
22. An extended Myc network contributes to glucose homeostasis in cancer and diabetes.
Peterson CW; Ayer DE
Front Biosci (Landmark Ed); 2011 Jun; 16(6):2206-23. PubMed ID: 21622171
[TBL] [Abstract][Full Text] [Related]
23. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.
Xiong J; Du Q; Liang Z
Oncogene; 2010 Sep; 29(35):4980-8. PubMed ID: 20562918
[TBL] [Abstract][Full Text] [Related]
24. Identification and analysis of the regulatory network of Myc and microRNAs from high-throughput experimental data.
Xiong L; Jiang W; Zhou R; Mao C; Guo Z
Comput Biol Med; 2013 Sep; 43(9):1252-60. PubMed ID: 23930820
[TBL] [Abstract][Full Text] [Related]
25. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.
DeBerardinis RJ; Cheng T
Oncogene; 2010 Jan; 29(3):313-24. PubMed ID: 19881548
[TBL] [Abstract][Full Text] [Related]
26. Cross-talk between ER and HER2 regulates c-MYC-mediated glutamine metabolism in aromatase inhibitor resistant breast cancer cells.
Chen Z; Wang Y; Warden C; Chen S
J Steroid Biochem Mol Biol; 2015 May; 149():118-27. PubMed ID: 25683269
[TBL] [Abstract][Full Text] [Related]
27. MicroRNAs as regulators and mediators of c-MYC function.
Jackstadt R; Hermeking H
Biochim Biophys Acta; 2015 May; 1849(5):544-53. PubMed ID: 24727092
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction.
Fogal V; Babic I; Chao Y; Pastorino S; Mukthavaram R; Jiang P; Cho YJ; Pingle SC; Crawford JR; Piccioni DE; Kesari S
Oncotarget; 2015 Jan; 6(2):1157-70. PubMed ID: 25528767
[TBL] [Abstract][Full Text] [Related]
29. Myc requires RhoA/SRF to reprogram glutamine metabolism.
Haikala HM; Marques E; Turunen M; Klefström J
Small GTPases; 2018 May; 9(3):274-282. PubMed ID: 27532209
[TBL] [Abstract][Full Text] [Related]
30. The molecular determinants of de novo nucleotide biosynthesis in cancer cells.
Tong X; Zhao F; Thompson CB
Curr Opin Genet Dev; 2009 Feb; 19(1):32-7. PubMed ID: 19201187
[TBL] [Abstract][Full Text] [Related]
31. Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach.
Chen L; Cui H
Int J Mol Sci; 2015 Sep; 16(9):22830-55. PubMed ID: 26402672
[TBL] [Abstract][Full Text] [Related]
32. p53 represses c-Myc through induction of the tumor suppressor miR-145.
Sachdeva M; Zhu S; Wu F; Wu H; Walia V; Kumar S; Elble R; Watabe K; Mo YY
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3207-12. PubMed ID: 19202062
[TBL] [Abstract][Full Text] [Related]
33. MYC and metabolism on the path to cancer.
Hsieh AL; Walton ZE; Altman BJ; Stine ZE; Dang CV
Semin Cell Dev Biol; 2015 Jul; 43():11-21. PubMed ID: 26277543
[TBL] [Abstract][Full Text] [Related]
34. The NF-κB member p65 controls glutamine metabolism through miR-23a.
Rathore MG; Saumet A; Rossi JF; de Bettignies C; Tempé D; Lecellier CH; Villalba M
Int J Biochem Cell Biol; 2012 Sep; 44(9):1448-56. PubMed ID: 22634383
[TBL] [Abstract][Full Text] [Related]
35. Mammalian Target of Rapamycin 2 (MTOR2) and C-MYC Modulate Glucosamine-6-Phosphate Synthesis in Glioblastoma (GBM) Cells Through Glutamine: Fructose-6-Phosphate Aminotransferase 1 (GFAT1).
Liu B; Huang ZB; Chen X; See YX; Chen ZK; Yao HK
Cell Mol Neurobiol; 2019 Apr; 39(3):415-434. PubMed ID: 30771196
[TBL] [Abstract][Full Text] [Related]
36. MYC sensitises cells to apoptosis by driving energetic demand.
Edwards-Hicks J; Su H; Mangolini M; Yoneten KK; Wills J; Rodriguez-Blanco G; Young C; Cho K; Barker H; Muir M; Guerrieri AN; Li XF; White R; Manasterski P; Mandrou E; Wills K; Chen J; Abraham E; Sateri K; Qian BZ; Bankhead P; Arends M; Gammoh N; von Kriegsheim A; Patti GJ; Sims AH; Acosta JC; Brunton V; Kranc KR; Christophorou M; Pearce EL; Ringshausen I; Finch AJ
Nat Commun; 2022 Aug; 13(1):4674. PubMed ID: 35945217
[TBL] [Abstract][Full Text] [Related]
37. Widespread microRNA repression by Myc contributes to tumorigenesis.
Chang TC; Yu D; Lee YS; Wentzel EA; Arking DE; West KM; Dang CV; Thomas-Tikhonenko A; Mendell JT
Nat Genet; 2008 Jan; 40(1):43-50. PubMed ID: 18066065
[TBL] [Abstract][Full Text] [Related]
38. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy.
Wang G; Wang J; Zhao H; Wang J; Tony To SS
Arch Biochem Biophys; 2015 Aug; 580():84-92. PubMed ID: 26151775
[TBL] [Abstract][Full Text] [Related]
39. miR-145 inhibits glutamine metabolism through c-myc/GLS1 pathways in ovarian cancer cells.
Li J; Li X; Wu L; Pei M; Li H; Jiang Y
Cell Biol Int; 2019 Aug; 43(8):921-930. PubMed ID: 31115975
[TBL] [Abstract][Full Text] [Related]
40. miR-296-3p Negatively Regulated by Nicotine Stimulates Cytoplasmic Translocation of c-Myc via MK2 to Suppress Chemotherapy Resistance.
Deng X; Liu Z; Liu X; Fu Q; Deng T; Lu J; Liu Y; Liang Z; Jiang Q; Cheng C; Fang W
Mol Ther; 2018 Apr; 26(4):1066-1081. PubMed ID: 29525743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
